Finance

Lists
Q2 2026 earnings • released • EPS beat +55.78% • Revenue beat +2.26%
See results
MDLN:NASDAQ
Medline Inc
$35.23
+2.09%
(+0.72) 1D
$35.68
+1.28% (+0.45)
Pre-market
Closed: Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDLN...
Open
$34.62
High
$35.81
Low
$34.03
Mkt. cap
46.32B
Avg. vol.
7.56M
Volume
664.00
P/E ratio
41.66
52-wk high
$50.88
52-wk low
$32.82
EPS
$0.85
Shares outstanding
877.35M
No. of employees
45K
Open
$34.62
High
$35.81
Low
$34.03
Mkt. cap
46.32B
Avg. vol.
7.56M
Volume
664.00
P/E ratio
41.66
52-wk high
$50.88
52-wk low
$32.82
EPS
$0.85
Shares outstanding
877.35M
No. of employees
45K
News stories
From sources across the web
About Medline Inc
CEO-
Employees45K
Founded1966
Headquarters-
SectorMedical device
Websitemedline.com
Analyst ratings
Based on 18 analysts giving stock ratings to MDLN in the past 3 months
Strong buy
Buy
17
Hold
1
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for MDLN in the last 3 months.
Highest
Current $35.23
$62.00 (+75.99%)
Average
$47.06 (+33.58%)
Lowest
$37.00 (+5.02%)
Analyst
Recommendation
Action
Price target
Projected
Date
Charles Rhyee
TD Cowen
Buy
Reiterated
$45.00
+27.7%
08/10/2026
Andrew Obin
Bank of America Securities
Buy
Maintained
-
-
08/06/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
$42.00
+19.2%
08/06/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$39.00
+10.7%
08/06/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
$45.00
+27.7%
08/06/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$47.00
+33.4%
08/05/2026
Jailendra Singh
Truist Financial
Buy
Maintained
$47.00
+33.4%
08/06/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
$48.00
+36.2%
08/06/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
$48.00
+36.2%
08/06/2026
Ryan Halsted
RBC Capital
Buy
Maintained
$46.00
+30.6%
08/05/2026
David Larsen
BTIG
Buy
Reiterated
$55.00
+56.1%
08/05/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
$37.00
+5%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
$45.00
+27.7%
08/05/2026
Patrick B Donnelly
Citi
Buy
Maintained
$45.00
+27.7%
08/05/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/05/2026
Kevin Caliendo
UBS
Buy
Maintained
$50.00
+41.9%
07/29/2026
Michael Cherny
Leerink Partners
Buy
Maintained
$52.00
+47.6%
06/12/2026
Glen Santangelo
Barclays
Buy
Reiterated
$45.00
+27.7%
06/01/2026
Ivan Feinseth
Tigress Financial
Buy
Reiterated
$62.00
+76%
05/13/2026
Lee Hambright
Bernstein
Buy
Reiterated
$54.00
+53.3%
05/07/2026
Unknown Analyst
Jefferies
Buy
Maintained
$53.00
+50.4%
05/07/2026
David Roman
Goldman Sachs
Buy
Maintained
$50.00
+41.9%
05/06/2026
Stephen Baxter
Wells Fargo
Hold
Reiterated
$47.00
+33.4%
05/07/2026
Jason Bednar
Piper Sandler
Buy
Maintained
$55.00
+56.1%
05/04/2026
Lisa Gill
J.P. Morgan
Buy
Reiterated
$53.00
+50.4%
03/10/2026
Patrick Wood
Morgan Stanley
Buy
Maintained
$48.00
+36.2%
02/25/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.50 / $0.32
+55.78%beat
Revenue / Est. (USD)
7.68B / 7.51B
+2.26%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.12B
7.79B
7.35B
7.68B
Cost of goods sold
5.24B
5.87B
5.51B
5.47B
Cost of revenue
5.24B
5.87B
5.51B
5.47B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.12B
1.26B
1.23B
1.30B
Operating expense
1.30B
1.47B
1.42B
1.82B
Total operating expenses
6.54B
7.34B
6.93B
7.29B
Operating income
574.00M
443.00M
422.00M
395.00M
Other non operating income
-
-6.00M
1.00M
-42.00M
EBT including unusual items
345.00M
206.00M
291.00M
235.00M
EBT excluding unusual items
351.00M
276.00M
291.00M
235.00M
Income tax expense
23.00M
26.00M
52.00M
96.00M
Effective tax rate
6.67%
12.62%
17.87%
40.85%
Other operating expenses
8.00M
30.00M
15.00M
348.00M
Net income
322.00M
182.00M
129.00M
60.00M
Net profit margin
4.53%
2.34%
1.75%
0.78%
Earnings per share
-
0.38
0.33
0.50
Interest and investment income
35.00M
34.00M
29.00M
49.00M
Interest expense
-248.00M
-200.00M
-165.00M
-168.00M
Net interest expenses
-213.00M
-166.00M
-136.00M
-119.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
827.00M
704.00M
676.00M
651.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps